Beam Therapeutics Inc. (BEAM)
NASDAQ·Healthcare·Biotechnology
$26.42
+0.49%
Mkt Cap $2.58B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (19 analysts)
$52.00
Range $26.00 – $80.00
Implied Upside
+96.8%
Consensus $52.00 vs current $26.42
NASDAQ·Healthcare·Biotechnology
$26.42
+0.49%
Mkt Cap $2.58B
Buy
5
Hold
0
Sell
0
Price Target (19 analysts)
$52.00
Range $26.00 – $80.00
+96.8%
Consensus $52.00 vs current $26.42